Expert in product and market development will oversee health technologies portfolio
Dr. Anurag Mairal, an expert in product and market development, has been named global program leader for Technology Solutions at PATH.
Dr. Mairal will oversee research and development, commercialization, and implementation of health technologies in the areas of maternal and neonatal health, nutrition, water and sanitation, health management information systems, reproductive health, vaccine-related technologies, and diagnostics for infectious and noncommunicable diseases.
"I am pleased to welcome Dr. Mairal, whose commitment to product and market development and experience working with global health stakeholders well positions him to lead PATH's technology solutions portfolio," said Jacqueline Sherris, vice president of Global Programs at PATH.
"PATH has a record of success in creating and implementing numerous health technologies and we look forward to Dr. Mairal's unique contribution to this legacy."
Dr. Mairal has an extensive background in medical device development, collaborating with partners in India, China, and other countries to advance product development, manufacturing, and distribution.
Most recently, Dr. Mairal served as consulting assistant professor at the Stanford University School of Medicine and director for global exchange at Stanford's Biodesign program.
Dr. Mairal cofounded and served as executive vice president of Orbees Medical, a consulting company that provides strategic advice and emerging market-development services to the global health care industry. He held several positions at Johnson & Johnson, including director of research and development and marketing efforts for cardiology-related medical devices.
Dr. Mairal earned an MS in chemical engineering from the Indian Institution of Technology in Mumbai. He holds a PhD in chemical engineering from the University of Colorado at Boulder and an MBA from the University of California at Berkeley. Dr. Mairal's work has been published in more than 20 publications, and he has been issued seven patents.
Beginning January 28, Dr. Mairal will be based in PATH's Seattle headquarters. He will spend part of his time in our South San Francisco office, and he will continue to serve in an advisory role at the Stanford Biodesign program.